Abstract

MicroRNA-21 (miR-21) is recognized as an oncomir and shows up-regulation in many types of human malignancy. The aim of this study was to investigate the association of miR-21 expression associated with HPV infection in normal and abnormal cervical tissues. Cervical tissue samples with different cytological or histopathological grades were investigated for HPV by PCR and for miR-21 and programmed cell death, protein 4 (PDCD4) expression using quantitative real-time PCR (qRT-PCR). Laser capture microdissection (LCM) of stromal and epithelial tissues and in situ hybridization (ISH) using locked nucleic acid (LNA) probes were performed on a subset of fixed specimens. Cell line experiments were conducted on fibroblasts stimulated in culture media from HeLa cells, which were then assessed for miR-21, PDCD4, IL-6 and α-SMA expression by qRT-PCR. Twenty normal cervical cell, 12 cervicitis, 14 cervical intraepithelial neoplastic I (CIN I), 22 CIN II-III and 43 cervical squamous cell carcinoma (SCC) specimens were investigated. miR-21 levels were significantly lower in normal than in abnormal tissues. The expression of miR-21 in HPV negative normal cytology was significantly lower than in HPV positive samples in abnormal tissue and SCC. The miR-21 expression was significantly higher in HPV negative cervicitis than HPV negative normal cells. LCM and ISH data showed that miR-21 is primarily expressed in the tumor-associated stromal cell microenvironment. Fibroblasts treated with HeLa cell culture media showed up-regulated expression of miR-21, which correlated with increased expression of α-SMA and IL-6 and with down-regulation of PDCD4. These results demonstrate that miR-21 is associated with HPV infection and involved in cervical lesions as well as cervicitis and its up-regulation in tumor-stroma might be involved in the inflammation process and cervical cancer progression.

Highlights

  • Cervical cancer is the second most common malignancy in women worldwide

  • HPV DNA was detected in 40% (8/20 cases) of normal cervical cells, 50% (5/12 cases) of cervicitis, 64.2% (9/14 cases) of cervical intraepithelial neoplastic I (CIN I), 72.7% (16/22 cases) of CIN II-III and 79% (34/43 cases) of squamous cell carcinoma (SCC)

  • Discussion miR-21 is a target of considerable interest because of its up-regulation demonstrated by quantitative real-time polymerase chain reaction (PCR) (qRT-PCR) in a variety of human cancers including cervical tumors [7,8,9, 14, 16, 19, 25]

Read more

Summary

Introduction

Cervical cancer is the second most common malignancy in women worldwide. High-risk human papillomavirus (HR-HPV) infection is recognized as the most important risk factor. Chronic over-expression of the HPV E6 and E7 oncogenes promote tumor progression by inducing genetic and epigenetic instability [1,2,3]. Epigenetic instability is impacted by microRNAs (miRNA or miR-). MiR- dysregulation is associated with a wide variety of human malignancies. Several miRs are reported to be involved in cervical cancer such as miRs-21, -23b, -34a, -143, -146a, -218 and miR-182; these miRs play crucial roles in cervical cell proliferation, differentiation and apoptosis [5,6,7,8,9,10,11,12,13]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call